CCIA
SRGA

Campbell & Co Investment Adviser’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Campbell & Co Investment Adviser’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,103
Closed -$152K – 568
2018
Q1 		$152K Buy
1,103
+37
+3% +$5.04K 0.13% 321
2017
Q4 		$131K Buy
1,066
+9
+0.9% +$1.24K 0.1% 358
2017
Q3 		$144K Buy
+1,057
New +$160K 0.12% 316

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCM
Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return
HC
Hillman Company Pittsburgh, Pennsylvania $283M AUM 23.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Campbell & Co Investment Adviser's SRGA Position: Q2 2018 in Review

Campbell & Co Investment Adviser sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2018, closing a stake of 1,103 shares — an estimated $152K sold.

Campbell & Co Investment Adviser first reported a position in SRGA in Q3 2017 and held it in 3 quarters. The position peaked at $152K in Q1 2018. 109 funds tracked by Wall St. Rank hold SRGA as of Q2 2018.

  • Campbell & Co Investment Adviser reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 1,103 Surgalign Holdings, Inc. Common Stock shares in Q2 2018, an estimated $152K.
  • Campbell & Co Investment Adviser first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2017 and held it in 3 quarters.
  • Campbell & Co Investment Adviser's Surgalign Holdings, Inc. Common Stock position peaked at $152K in Q1 2018.
  • 109 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2018.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2018, filed 13 Jul 2018.